14fxL

Key Stories from the past week: Tariffs on pause - but tensions are not

Macro
Saxo Be Invested
Saxo

The implications of “Liberation Day” reciprocal tariffs & the subsequent uncertainty that came along with them, carried into this week in full force. A global selloff in equity markets & broad risk-off sentiment saw investors looking for safe havens in currencies and gold as the looming recession fears started to amplify & the VIX briefly exceeded 60. Equity Index moves included some of the largest seen in years, with Nasdaq closing a day up +12% & a heavy selloff in US treasuries saw 10yr yields surge 50bps in a significant move – which may have contributed to the US pulling the brakes on some tariffs in a 90-day pause announcement. Read more in this week’s key stories below:

Tariff pause brings relief rally
US President Trump announced a 90-day pause on higher reciprocal tariffs that were due to hit dozens of trade partners on Wednesday. In a sign of relief US equities posted historic gains with the S&P 500 surging 9.5% and the Nasdaq climbing 12.16%, its best single-day performance since 2001. The overall tariff angst remains unresolved with the bounce looking fragile.
Trump's tariff pause sparks rally

Treasury dump
Bonds were the talk of the town this week, as 10-year treasuries spiked 50 basis points in a significant move to 4.5%. While the broader equity market selloff carried into the start of the week, US treasuries suddenly came under heavy selling pressure, which could have been a component of the decision from President Trump to hit pause on the dramatic reciprocal tariff program.
Why are bonds losing appeal in these uncertain times?

Investors seek shelter in currencies
The US Dollar retreated for the fourth consecutive session this week as markets sought safe havens in the Euro, Japanese Yen, Swiss Franc, and Gold. The tariff escalations have led investors to demand higher yields for US debt, as the outlook for the US economy becomes bleaker and the tariff plans remain unclear. The Euro rallied to a three-year high, breaking the 100-month moving average, as German Bunds attracted investors. Meanwhile, the Japanese Yen has strengthened for four consecutive months.
SaxoTraderGO

Big Pharma face targeted tariffs
Speaking at a fundraiser dinner for his Republican Party on Tuesday, Trump said: "We're going to be announcing very shortly a major tariff on pharmaceuticals.” a move that could end decades of low-cost global trade in medicines. In 2024, pharmaceuticals were the EU's largest export to the US, worth a reported $127bn (£100bn).
Potential tariffs for Pharma

Next week we expect that tariff announcements and geopolitical developments will once again dominate. Scheduled earnings releases include Goldman Sachs (Mon), Johnson & Johnson, Bank of America, Citigroup (Tues), ASML, Abbott Laboratories (Weds), Taiwan Semiconductor, UnitedHealth, Netflix, American Express (Thurs). Focus will be as much on guidance and commentary around tariffs as much as the Q1 results. Key economic data to watch for are German Apr ZEW (Tues), China Q1 GDP, US Mar Retail Sales, Fed Chair Powell speaks (Weds), ECB interest rate decision, Atlanta Fed Q1 GDPNow (Thurs). 

 

Outrageous Predictions 2026

01 /

  • Executive Summary: Outrageous Predictions 2026

    Outrageous Predictions

    Executive Summary: Outrageous Predictions 2026

    Saxo Group

    Read Saxo's Outrageous Predictions for 2026, our latest batch of low probability, but high impact ev...
  • A Fortune 500 company names an AI model as CEO

    Outrageous Predictions

    A Fortune 500 company names an AI model as CEO

    Charu Chanana

    Chief Investment Strategist

    Can AI be trusted to take over in the boardroom? With the right algorithms and balanced human oversi...
  • Dollar dominance challenged by Beijing’s golden yuan

    Outrageous Predictions

    Dollar dominance challenged by Beijing’s golden yuan

    Charu Chanana

    Chief Investment Strategist

    Beijing does an end-run around the US dollar, setting up a framework for settling trade in a neutral...
  • Obesity drugs for everyone – even for pets

    Outrageous Predictions

    Obesity drugs for everyone – even for pets

    Jacob Falkencrone

    Global Head of Investment Strategy

    The availability of GLP-1 drugs in pill form makes them ubiquitous, shrinking waistlines, even for p...
  • Dumb AI triggers trillion-dollar clean-up

    Outrageous Predictions

    Dumb AI triggers trillion-dollar clean-up

    Jacob Falkencrone

    Global Head of Investment Strategy

    Agentic AI systems are deployed across all sectors, and after a solid start, mistakes trigger a tril...
  • Quantum leap Q-Day arrives early, crashing crypto and destabilizing world finance

    Outrageous Predictions

    Quantum leap Q-Day arrives early, crashing crypto and destabilizing world finance

    Neil Wilson

    Investor Content Strategist

    A quantum computer cracks today’s digital security, bringing enough chaos with it that Bitcoin crash...
  • SpaceX announces an IPO, supercharging extraterrestrial markets

    Outrageous Predictions

    SpaceX announces an IPO, supercharging extraterrestrial markets

    John J. Hardy

    Global Head of Macro Strategy

    Financial markets go into orbit, to the moon and beyond as SpaceX expands rocket launches by orders-...
  • Taylor Swift-Kelce wedding spikes global growth

    Outrageous Predictions

    Taylor Swift-Kelce wedding spikes global growth

    John J. Hardy

    Global Head of Macro Strategy

    Next year’s most anticipated wedding inspires Gen Z to drop the doomscrolling and dial up the real w...
  • Britain’s Great EU Backdoor Return

    Outrageous Predictions

    Britain’s Great EU Backdoor Return

    Neil Wilson

    Investor Content Strategist

    Faced with rolling fiscal, economic, trade and political crises the UK government sneaks back into t...
  • Despite concerns, U.S. 2026 mid-term elections proceed smoothly

    Outrageous Predictions

    Despite concerns, U.S. 2026 mid-term elections proceed smoothly

    John J. Hardy

    Global Head of Macro Strategy

    In spite of outstanding threats to the American democratic process, the US midterms come and go cord...

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details. Past Performance is not indicative of future results.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992